the myCME.com take:
In advance of its annual meeting this weekend, the American Society of Hematology (ASH) today named five additional tests, treatments, and procedures in hematology that clinicians and patients should question in certain cases.
This adds to the list the Society released last year as part of the Choosing Wisely campaign, a program developed by the ABIM Foundation to encourage conversations between patients and physicians about the potential benefits and harms of certain procedures. Here’s what you need to know about the new items on the list:
- An anticoagulant should not be used for longer than 3 months in a patient with a first venous thromboembolism occurring along with a major transient risk factor.
- Routine transfusion should not be given to patients with sickle cell disease for chronic anemia or uncomplicated pain crisis without an appropriate clinical indication.
- Baseline or routine surveillance computer tomography (CT) scans should not be performed in patients with asymptomatic early-stage chronic lymphocytic leukemia.
- Tests or treatment for suspected heparin-induced thrombocytopenia (HIT) should not be given in patients with a low pre-test probability of HIT.
- Patients with immune thrombocytopenic purpura should not be treated in the absence of bleeding or very low platelet count.